AOTI (AOTI.L) Stock Analysis & Winston Score

AOTI makes medical devices that help heal chronic wounds, like diabetic foot ulcers and other hard-to-treat skin injuries. Its main product uses a technology called topical wound oxygen therapy, which delivers oxygen directly to wounds to speed up healing. The company sells primarily to hospitals, wound care clinics, and healthcare systems. AOTI generates revenue by selling and renting its wound therapy devices and related supplies to healthcare providers, mainly in the United States and Europe. The company is small, with a market cap around $100 million, but benefits from strong gross margins near 88% and a niche position in the wound care market with FDA-cleared technology. Key growth depends on expanding insurance reimbursement coverage and gaining wider clinical adoption, though the company faces risks from larger medical device competitors and the challenge of reaching consistent profitability.